Wulff, Hansen & Co. Novartis Ag Transaction History
Wulff, Hansen & Co.
- $101 Million
- Q1 2025
A detailed history of Wulff, Hansen & Co. transactions in Novartis Ag stock. As of the latest transaction made, Wulff, Hansen & Co. holds 2,930 shares of NVS stock, worth $340,407. This represents 0.32% of its overall portfolio holdings.
Number of Shares
2,930
Previous 2,945
0.51%
Holding current value
$340,407
Previous $286,000
13.99%
% of portfolio
0.32%
Previous 0.29%
Shares
9 transactions
Others Institutions Holding NVS
# of Institutions
1,544Shares Held
141MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.37 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.21 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$1 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$820 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$786 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $250B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...